1Bataller R,Brenner DA. Liver fibrosis[J].{H}Journal of Clinical Investigation,2005.209-218.
2Ellis E L,Mann DA. Clinical evidence for the regression of liver fibrosis[J].{H}Journal of Hepatology,2012.1171-1180.
3Ramachandran P,Iredale JP. Liver fibrosis:a bidirectional model of fibrogenesis and resolution[J].{H}QUARTERLY JOURNAL OF MEDICINE,2012.813-817.
4Kocabayoglu P,Friedman SL. Cellular basis of hepatic fibrosis and its role in inflammation and cancer[J].Front Biosci (Schol Ed),2013.217-230.
5Li M,Wang B,Zhang M. Symbiotic gut microbes modulate human metabolic phenotypes[J].{H}Proceedings of the National Academy of Sciences(USA),2008.2117-2122.
6Lu H,Wu Z,Xu W. Intestinal microbiota was assessed in cirrhotic patients with hepatitis B virus infection.Intestinal microbiota of HBV cirrhotic patients[J].{H}Microbial Ecology,2011.693-703.
7Xu M,Wang B,Fu Y. Changes of fecal Bifidobacterium species in adult patients with hepatitis B virus-induced chronic liver disease[J].{H}Microbial Ecology,2012.304-313.
8Xie G,Zhang S,Zheng X. Metabolomics approaches for characterizing metabolic interactions between host and its commensal microbes[J].{H}ELECTROPHORESIS,2013.2787-2798.
9Zhang AH,Sun H,Qiu S. NMR-based metabolomics coupled with pattern recognition methods in biomarker discovery and disease diagnosis[J].{H}Magnetic Resonance in Chemistry,2013.549-556.
10Hernandez-Gea V,Friedman SL. Pathogenesis of liver fibrosis[J].Annu Rev Pathol,2011.425-456.
